Related Experiment Videos
Hyperuricemia, gout, and renal function after liver transplantation
D A Neal1, B D Tom, A E Gimson
1Department of Medicine, University of Cambridge, School of Clinical Medicine, Addenbrooke's NHS Trust, United Kingdom.
Transplantation
|December 1, 2001
Summary
Liver transplantation is frequently linked to hyperuricemia. Allopurinol treatment effectively lowers serum creatinine in liver transplant recipients experiencing gout or renal impairment.
Area of Science:
- Nephrology
- Hepatology
- Pharmacology
Background:
- Hyperuricemia and gout are known complications of renal and cardiac transplantation.
- The incidence of hyperuricemia following liver transplantation is less understood.
- This study retrospectively evaluated hyperuricemia prevalence in liver transplant recipients.
Purpose of the Study:
- To determine the prevalence of hyperuricemia in liver transplant recipients.
- To investigate the association between hyperuricemia and renal function post-liver transplant.
- To assess the efficacy of allopurinol in managing hyperuricemia and associated renal impairment.
Main Methods:
- Retrospective analysis of 134 consecutive liver transplant recipients.
- Measurement of serum uric acid and creatinine levels.
- Evaluation of allopurinol treatment outcomes in a subset of patients.
Main Results:
- Hyperuricemia was present in 47% of liver transplant recipients.
- Hyperuricemic patients exhibited higher serum creatinine levels.
- Allopurinol treatment significantly reduced serum creatinine in patients with gout and renal impairment.
Conclusions:
- Liver transplantation is significantly associated with hyperuricemia.
- Allopurinol demonstrates efficacy in improving renal function in specific post-transplant patient groups.
- Further research into managing hyperuricemia post-liver transplant is warranted.